The only available text to focus primarily on Acute Respiratory Distress Syndrome (ARDS).

Thoroughly revised content and ten new chapters provide pulmonologists with the latest developments and applications of pharmacological and mechanical therapies needed to treat the debilitating and difficult condition of ARDS.

Highlights include:







the definition, epidemiology, pathology, and pathogenesis of ARDS
complications such as transfusion-related injury, and endothelium and vascular dysfunction
the long-term outcomes of ARDS
host defense and infection
the latest developments in ARDS therapy: glucocorticoid therapy, surfactant therapy, mechanical ventilation, and mesenchymal stem cells
predictive factors: gene expression profiling and biomarkers, and chemokines and cytokines
advances in management strategies: fluid management, non-pulmonary and non-sepsis management, and glucose control